Compare HLIO & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLIO | PAHC |
|---|---|---|
| Founded | 1970 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 2014 |
| Metric | HLIO | PAHC |
|---|---|---|
| Price | $59.28 | $39.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $52.40 | $31.25 |
| AVG Volume (30 Days) | 259.7K | ★ 265.8K |
| Earning Date | 02-23-2026 | 02-04-2026 |
| Dividend Yield | 0.64% | ★ 1.25% |
| EPS Growth | N/A | ★ 288.74 |
| EPS | 1.01 | ★ 1.67 |
| Revenue | $807,700,000.00 | ★ $1,399,676,000.00 |
| Revenue This Year | $4.43 | $15.34 |
| Revenue Next Year | $1.03 | $3.28 |
| P/E Ratio | $55.69 | ★ $22.97 |
| Revenue Growth | N/A | ★ 33.72 |
| 52 Week Low | $24.76 | $16.16 |
| 52 Week High | $58.80 | $46.42 |
| Indicator | HLIO | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 66.37 | 52.05 |
| Support Level | $52.65 | $36.47 |
| Resistance Level | $56.85 | $38.49 |
| Average True Range (ATR) | 1.93 | 1.42 |
| MACD | 0.20 | 0.12 |
| Stochastic Oscillator | 97.11 | 65.50 |
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.